United Kingdom· GB-APID-14390411000001100
Pulmicort 200 Turbohaler
A budesonide product containing budesonide, registered in United Kingdom by Sigma Pharmaceuticals Plc. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Budesonide is registered in 15 of 19 countries.
Countries holding a registration under ATC R03BA02 (budesonide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Budesonide · ATC R03BA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Budesonide
- Manufacturer
- Sigma Pharmaceuticals Plc
- Country
- United Kingdom (GB)
- ATC code
- R03BA02
- ATC class
- Budesonide
- Defined daily dose
- 0.8 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
686 interactions on record for budesonide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Budesonide · interactions on record
686 records
- 62 severe
- 260 moderate
- 27 minor
- 337 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- Bempedoic acidC10AX15severe
- MifepristoneG03XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03BA02
Budesonide, as other registers publish it.
- ItalyAIRCORTITALCHIMICI S.P.A.
- ItalyAIRCORTITALCHIMICI S.P.A.
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- PolandBenodilZakłady Farmaceutyczne POLPHARMA S.A.
- PolandBenodilZakłady Farmaceutyczne POLPHARMA S.A.
- PolandBenodilZakłady Farmaceutyczne POLPHARMA S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b33611d1-5d09-42b7-b896-8d5e706704c0 GET /v1/drugs/b33611d1-5d09-42b7-b896-8d5e706704c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "14390411000001100",
"desc": "Pulmicort 200 Turbohaler (Sigma Pharmaceuticals Plc)",
"form": "Inhalation powder",
"vpid": "35912411000001100",
"source": "dmd",
"vtm_id": "774924004",
"strength": "200 microgram",
"substance": "Budesonide",
"ingredient": "Budesonide",
"supplier_code": "2087601000001106"
}See everything about budesonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.